ROYAL BANK OF CANADA - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 2 filers reported holding CARIBOU BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$153,000
+350.0%
31,940
+294.0%
0.00%
Q2 2023$34,000
+17.2%
8,106
+52.3%
0.00%
Q1 2023$29,000
-46.3%
5,321
-37.5%
0.00%
Q4 2022$54,000
+80.0%
8,508
+198.2%
0.00%
Q3 2022$30,000
+114.3%
2,853
+15.3%
0.00%
Q2 2022$14,000
-68.2%
2,474
-47.6%
0.00%
Q1 2022$44,000
-24.1%
4,724
+25.7%
0.00%
Q4 2021$58,000
-12.1%
3,758
+36.3%
0.00%
Q3 2021$66,0002,7580.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q4 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 474,067$2,014,78515.70%
Memorial Sloan Kettering Cancer Center 544,196$2,312,8337.30%
Elmwood Wealth Management, Inc. 2,364,415$10,048,7644.68%
PFM Health Sciences, LP 5,570,869$23,676,1930.92%
Avidity Partners Management LP 2,758,600$11,724,0500.41%
Green Alpha Advisors, LLC 105,826$449,7600.30%
Bruce & Co., Inc. 200,000$850,0000.24%
SVB FINANCIAL GROUP 20,714$88,0350.17%
Rokos Capital Management LLP 2,748,139$11,202,7890.11%
Tekla Capital Management LLC 567,147$2,410,3750.09%
View complete list of CARIBOU BIOSCIENCES INC shareholders